Sales decline 13.37% to Rs 30.77 crore
Net profit of Medicamen Biotech declined 16.15% to Rs 3.22 crore in the quarter ended September 2020 as against Rs 3.84 crore during the previous quarter ended September 2019. Sales declined 13.37% to Rs 30.77 crore in the quarter ended September 2020 as against Rs 35.52 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales30.7735.52 -13 OPM %18.0416.08 -PBDT5.305.84 -9 PBT4.605.22 -12 NP3.223.84 -16Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
